(Q45749670)

English

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

scientific article published in May 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

0 references

1 reference

based on heuristic

inferred from title

0 references

author name string

Robinson HL

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Montefiori DC

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Johnson RP

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Manson KH

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Kalish ML

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Lifson JD

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Rizvi TA

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Lu S

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Hu SL

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Mazzara GP

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Panicali DL

11

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Herndon JG

12

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Glickman R

13

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Candido MA

14

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Lydy SL

15

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Wyand MS

16

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

McClure HM

17

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Nature Medicine

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

526-534

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Why do we not have an HIV vaccine and how can we make one? .

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological and virologic characteristics of primary HIV infection

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuated HIV vaccine: caveats.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

An evaluation of partner notification for HIV infection in genitourinary medicine clinics in England.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-Neutralizing Antibodies in Rabbits Immunized with HIV-1 gp160 Purified from Simian Cells Infected with a Recombinant Vaccinia Virus

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Formation of Lentivirus Particles by Mammalian Cells Infected with Recombinant Fowlpox Virus

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Toward an HIV type 1 vaccine that generates potent, broadly cross-reactive neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of cytokines in determining T-lymphocyte function

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquisition of lymphokine-producing phenotype by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Live attenuated AIDS vaccines: hazards and hopes

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay.

1 reference

https://api.crossref.org/works/10.1038%2F8406

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Dimensions Publication ID

0 references

release_mss2xnl7ubbeznjxpq2daj5aha

1 reference

https://api.fatcat.wiki/v0/release/mss2xnl7ubbeznjxpq2daj5aha

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/10229229

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45749670&oldid=2207303948"